PCVX 3/31/22 cash=$352M (including $108M raised in the Jan 2022 public offering): https://www.globenewswire.com/news-release/2022/05/09/2439081/0/en/Vaxcyte-Reports-First-Quarter-2022-Financial-Results-and-Provides-Business-Update.html I’m not a fan of PCVX, but I give them credit for raising cash in January (even at the steep discount to the then-current share price).